Sulfanilamide Prices Trend and Forecast

North America

At the beginning of October 2022, the North American market, particularly the USA, had an inclined price trend for Sulfanilamide. The prices of Sulfanilamide remained on the higher side due to increased end-user demand balanced with adequate supplies among market participants. The market sentiments for Sulfanilamide in the USA were supported by slowing economic activity amid rising borrowing prices, consumer expenditure that increased 0.1% after increasing 0.9% in October, a reduction in trade interruption, and shipment costs. Sulfanilamide was priced at USD 27325 /MT CFR Los Angeles in the USA up until November. Prices decreased dramatically at the close of the fourth quarter, supported by decreased inquiries and the temporary closure of the domestic market due to the New Year's Holidays. 

APAC

By the end of 2022, Sulfanilamide Prices drastically decreased in the Asia Pacific area, mainly in China. As the fourth quarter of 2022 got underway, the market for Sulfanilamide saw a bright future as demand shifted significantly in the direction of the previous month's trend. After November, less supply disruption and port congestion in the nations that were the main importers helped to support the price trends for Sulfanilamide, which eventually settled at USD 21000 /MT FOB Shanghai. Since the COVID-19 outbreak and subsequent lockdowns have slowed economic growth and negatively impacted market sentiment for many commodities—including Sulfanilamide in China—demand in China has remained essentially dormant.

Europe

Sulfanilamide's European market followed a similar path in the fourth quarter of 2022. As the demand from the end-user pharmaceutical business increased and was balanced by the overall supplies among the market participants, the market initially started off on a positive note up until November. At USD 29250/MT CFR Hamburg after November, the witnesses for the Sulfanilamide pricing were assembled. Additionally, the downstream business began to moderately increase its demands for rates on doxepin hydrochloride in November, which contributed to the maintenance of higher-than-average costs. Due to suppliers' high stock levels as a result of the market's brief suspension, fresher orders fell in December 2022.

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.